PI
IBB icon

PFG Investments’s iShares Biotechnology ETF IBB Stock Holding History

PFG Investments’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$871K Buy
4,581
+365
+9% +$62.7K 0.03% 431
2026
Q1 		$712K Sell
4,216
-113
-3% -$19.3K 0.03% 465
2025
Q4 		$731K Sell
4,329
-9
-0.2% -$1.46K 0.03% 436
2025
Q3 		$626K Sell
4,338
-56
-1% -$7.64K 0.03% 482
2025
Q2 		$556K Sell
4,394
-1,370
-24% -$168K 0.03% 487
2025
Q1 		$737K Sell
5,764
-3,555
-38% -$482K 0.05% 370
2024
Q4 		$1.23M Buy
9,319
+661
+8% +$92.9K 0.08% 245
2024
Q3 		$1.26M Buy
8,658
+1
+0% +$145 0.08% 240
2024
Q2 		$1.19M Sell
8,657
-607
-7% -$81K 0.08% 226
2024
Q1 		$1.27M Buy
9,264
+4,867
+111% +$665K 0.08% 286
2023
Q4 		$597K Buy
4,397
+2,384
+118% +$291K 0.11% 208
2023
Q3 		$246K Buy
2,013
+93
+5% +$11.8K 0.05% 409
2023
Q2 		$244K Buy
1,920
+17
+0.9% +$2.21K 0.04% 419
2023
Q1 		$246K Buy
+1,903
New +$249K 0.05% 393

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

PFG Investments's IBB Position: Q2 2026 in Review

PFG Investments increased its iShares Biotechnology ETF (IBB) stake by 8.7% in Q2 2026, buying an estimated $62.7K and bringing the position to 4,581 shares worth $871K. The position accounts for 0.03% of the portfolio, ranked #431.

PFG Investments first reported a position in IBB in Q1 2023 and has held it in 14 quarters since. The position peaked at $1.27M in Q1 2024. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • PFG Investments held 4,581 shares of iShares Biotechnology ETF worth $871K as of Q2 2026.
  • PFG Investments bought 365 iShares Biotechnology ETF shares in Q2 2026, an estimated $62.7K.
  • iShares Biotechnology ETF made up 0.03% of PFG Investments's portfolio in Q2 2026, its #431 holding.
  • PFG Investments first reported a position in iShares Biotechnology ETF in Q1 2023 and has held it in 14 quarters since.
  • PFG Investments's iShares Biotechnology ETF position peaked at $1.27M in Q1 2024.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on PFG Investments's 13F filing for Q2 2026, filed 23 Jul 2026.